A systematic review of microRNAs in patients with hypertrophic cardiomyopathy
FL Scolari, LS Faganello, HI Garbin, BP e Mattos… - International journal of …, 2021 - Elsevier
Abstract Background Several microRNAs (miRNA) have been associated with hypertrophic
cardiomyopathy (HCM), but studies differ regarding methods employed. In an attempt to …
cardiomyopathy (HCM), but studies differ regarding methods employed. In an attempt to …
Bta‐miR‐149‐5p inhibits proliferation and differentiation of bovine adipocytes through targeting CRTCs at both transcriptional and posttranscriptional levels
MicroRNAs are small, single stranded, and noncoding RNAs that have been proven to be
potent regulators of adipogenesis. However, the role of bta‐miR‐149‐5p in regulating …
potent regulators of adipogenesis. However, the role of bta‐miR‐149‐5p in regulating …
[HTML][HTML] NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression
T Wang, M Zhai, S Xu, M Ponnusamy, Y Huang… - Theranostics, 2020 - ncbi.nlm.nih.gov
Mitochondrial dysfunction is involved in the pathogenesis of various cardiovascular
disorders. Although mitochondrial dynamics, including changes in mitochondrial fission and …
disorders. Although mitochondrial dynamics, including changes in mitochondrial fission and …
SP1‐induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up‐regulation of PCDH17
Y Long, L Wang, Z Li - Journal of Cellular and Molecular …, 2020 - Wiley Online Library
Cardiac hypertrophy (CH) is a common cardiac disease and is closely associated with heart
failure. Protocadherin 17 (PCDH17) was reported to aggravate myocardial infarction …
failure. Protocadherin 17 (PCDH17) was reported to aggravate myocardial infarction …
Nucleoporins in cardiovascular disease
RD Burdine, CC Preston, RJ Leonard… - Journal of molecular and …, 2020 - Elsevier
Cardiovascular disease is a pressing health problem with significant global health, societal,
and financial burdens. Understanding the molecular basis of polygenic cardiac pathology is …
and financial burdens. Understanding the molecular basis of polygenic cardiac pathology is …
[HTML][HTML] LncRNA4930473A02Rik promotes cardiac hypertrophy by regulating TCF7 via sponging miR-135a in mice
J Ren, H Qi, C Song, L Ba, R Liu, X Feng, L Wang… - Cell Death …, 2021 - nature.com
Cardiac hypertrophy is a common pathological change accompanied by various
cardiovascular diseases; however, its underlying mechanisms remain elusive. Mounting …
cardiovascular diseases; however, its underlying mechanisms remain elusive. Mounting …
[HTML][HTML] Identification of TGF-β-related genes in cardiac hypertrophy and heart failure based on single cell RNA sequencing
K Huang, H Wu, X Xu, L Wu, Q Li, L Han - Aging (Albany NY), 2023 - ncbi.nlm.nih.gov
Background: Heart failure (HF) remains a huge medical burden worldwide. Pathological
cardiac hypertrophy is one of the most significant phenotypes of HF. Several studies have …
cardiac hypertrophy is one of the most significant phenotypes of HF. Several studies have …
[HTML][HTML] Aortic disease and cardiomyopathy in patients with a novel DNMT3A gene variant causing Tatton-Brown–Rahman syndrome
D Zebrauskiene, E Sadauskiene, J Dapkunas… - Clinical …, 2024 - ncbi.nlm.nih.gov
Abstract Tatton-Brown–Rahman syndrome (TBRS) is a rare congenital genetic disorder
caused by autosomal dominant pathogenic variants in the DNA methyltransferase DNMT3A …
caused by autosomal dominant pathogenic variants in the DNA methyltransferase DNMT3A …
Identification and validation of the miRNA–mRNA regulatory network in fetoplacental arterial endothelial cells of gestational diabetes mellitus
L He, X Wang, Y Jin, W Xu, Y Guan, J Wu, S Han… - …, 2021 - Taylor & Francis
Gestational diabetes mellitus (GDM) increases the risk of fetal heart malformations, though
little is known about the mechanism of hyperglycemia-induced heart malformations. Thus …
little is known about the mechanism of hyperglycemia-induced heart malformations. Thus …
Integrative bioinformatics analysis reveals that Infarct‐Mediated overexpression of potential miR‐662/CREB1 pathway‐induced neuropeptide VIP is associated with …
P Zhang, B Liu - Disease Markers, 2021 - Wiley Online Library
Background. Neuropeptide levels are closely associated with the development and
maintenance of atrial fibrillation (AF) after myocardial infarction (MI). This study was aimed at …
maintenance of atrial fibrillation (AF) after myocardial infarction (MI). This study was aimed at …